
Are you looking to buy GlaxoSmithKline stocks? Chech our BAMagazine with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:GSK! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about GlaxoSmithKline stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Average volume
5.81 million shs
MARKET CAP
$88.55 billion
Stock exchange
NYSE
Buy this stock!
Below is a quick guide on how to buy NYSE:GSK stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy GlaxoSmithKline shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy GlaxoSmithKline – Search for “”NYSE:GSK”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought GlaxoSmithKline stocks with 0% commission!.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
13 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for GlaxoSmithKline in the last year. There are currently 4 sell ratings, 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “hold” GlaxoSmithKline stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
Wall Street analysts have given GlaxoSmithKline a “Hold” rating, but there may be better short-term opportunities in the market. Some of BAMagazine’s past winning trading ideas have resulted in 5-15% weekly gains. BAMagazine just released five new trading ideas, but GlaxoSmithKline wasn’t one of them. BAMagazine thinks five stocks may be even better buys in the how to buy stocks guide.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:GSK stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy GlaxoSmithKline stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy GlaxoSmithKline stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “NYSE:GSK stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some NYSE:GSK stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:GSK is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy GlaxoSmithKline stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for GlaxoSmithKline.
GlaxoSmithKline plc (NYSE:GSK) released its quarterly earnings data on Tuesday, February, 2nd. The pharmaceutical company reported $0.62 EPS for the quarter, missing the Zacks’ consensus estimate of $0.64 by $0.02. The pharmaceutical company had revenue of $8.74 billion for the quarter, compared to the consensus estimate of $8.71 billion. GlaxoSmithKline had a net margin of 18.50% and a trailing twelve-month return on equity of 29.60%. The company’s revenue was down 1.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.39 earnings per share.
View GlaxoSmithKline’s earnings history.
GlaxoSmithKline’s stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GSK shares have decreased by 11.3% and is now trading at $35.38.
GlaxoSmithKline declared a quarterly dividend on Thursday, February 4th. Investors of record on Friday, February 19th will be given a dividend of $0.628 per share on Thursday, April 8th. This represents a $2.51 annualized dividend and a dividend yield of 7.10%. The ex-dividend date is Thursday, February 18th. This is a positive change from GlaxoSmithKline’s previous quarterly dividend of $0.50.
View GlaxoSmithKline’s dividend history.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:GSK stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.79%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. GlaxoSmithKline does not yet have a strock track record of dividend growth. The dividend payout ratio of GlaxoSmithKline is 64.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend.
View GlaxoSmithKline’s dividend history.
GlaxoSmithKline’s management team includes the following people:
Ms. Emma N. Walmsley, CEO & Director (Age 51)
Mr. Iain James Mackay, CFO & Exec. Director (Age 59)
Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 58)
Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 60)
Ms. Sarah Elton-Farr, Head of Investor Relations
Mr. Nick Hirons, Sr. VP of Global Ethics & Compliance
Mr. James Ford, Sr. VP & Gen. Counsel
Ms. Sally Jackson, Sr. VP of Global Communications & CEO Office
Ms. Diana Conrad, Sr. VP of HR
Mr. David Simon Redfern, Chief Strategy Officer (Age 55)
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Abbott Laboratories (ABT), Novartis (NVS), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Bayer Aktiengesellschaft (BAYRY) and Vertex Pharmaceuticals (VRTX).
View all of GSK’s competitors.
Based on aggregate information from BAMagazine watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA).
GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol “GSK.”
Who are GlaxoSmithKline’s major shareholders?
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
GSK stock was sold by a variety of institutional investors in the last quarter, including Schafer Cullen Capital Management Inc, BlackRock Inc., Boston Partners, Aperio Group LLC, Nepsis Inc., Avalon Investment & Advisory, Janney Montgomery Scott LLC, and Chemung Canal Trust Co..
View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks.
GSK stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Fisher Asset Management LLC, Galibier Capital Management Ltd., First Trust Advisors LP, Douglas Lane & Associates LLC, Kestra Advisory Services LLC, Koshinski Asset Management Inc., and Capstone Triton Financial Group LLC.
View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks.
Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, DEGiro Review, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review and many more. Read one of the reviews to find out everything about the broker and start buying stocks now.
One share of GSK stock can currently be purchased for approximately $35.38.
GlaxoSmithKline has a market capitalization of $88.75 billion and generates $43.10 billion in revenue each year. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis.
GlaxoSmithKline employs 99,437 workers across the globe.
At BAMagazine.com we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy GlaxoSmithKline?
The safest and easiest way to buy NYSE:GSK is by using a regulated broker like eToro. You can open an account with the platform, make a deposit and buy this investment all in under 5 minutes from start to finish.
Another option is using a regulated exchange like Binance or Coinbase. You can open an account with these exchanges and start buying or trading. ?
Where to buy GlaxoSmithKline stock?
You will first want to find a licensed broker that supports NYSE:GSK stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:GSK stocks in a safe and complete environment.
Is NYSE:GSK stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:GSK stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is GlaxoSmithKline stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:GSK is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in GlaxoSmithKline stock.
How do you trade GlaxoSmithKline stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for GlaxoSmithKline stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:GSK stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell GlaxoSmithKline stock?
To sell your NYSE:GSK stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best GlaxoSmithKline stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:GSK stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
![]() | Our score ★★★★★ | |
![]() | Our score ★★★★★ | |
![]() | Our score ★★★★★ |
Newsletter
![]() |
Our score |
0% commission |
Logo | Name | Ticker | Our rank | More information | Buy this coin |
---|---|---|---|---|---|
![]() | Chesapeake Energy | CHK | ★★★★★ | Comprar Bitcoin | |
![]() | Ethereum | ETH | ★★★★★ | Comprar Ethereum | |
![]() | Binance Coin | ETH | ★★★★★ | Comprar Binance Coin | |
![]() | Tether | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Solana | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | XRP | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin | |
![]() | Cardano | ETH | ★★★★★ | Comprar Bitcoin |
All EPA Stocks More Information EPA stocks What Is the Paris Stock Exchange (EPA)? Now
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
BAMagazine Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
BAMagazine Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 BAMagazine.Finance | All rights reserved.